![Bo Anders Ljungqvist](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bo Anders Ljungqvist
Directeur des opérations chez RhoVac ApS
Provenance du réseau au premier degré de Bo Anders Ljungqvist
Entité | Type d'entité | Industrie | |
---|---|---|---|
Extinct | Biotechnology | 9 | |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
RhoVac ApS
![]() RhoVac ApS Pharmaceuticals: MajorHealth Technology Part of Chosa Oncology AB, RhoVac ApS is a Danish company that aims to prevent cancer recurrence and progression after primary tumor therapy. The company is based in Hørsholm, Denmark. The company's clinical phase II product, iCIP™ - Precision LiPlaCis® & DRP® with Breakthrough designation option, consists of LiPlaCis® and its Drug Response. Anders Månsson has been the CEO of the company since 2019.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Invest AD Asset Management PJSC
![]() Invest AD Asset Management PJSC Financial ConglomeratesFinance Invest AD Asset Management PJSC (Invest AD) is the sovereign wealth manager of government-owned Abu Dhabi Investment Council. The firm was founded in 1977 and is headquartered in Abu Dhabi. Invest AD provides asset management services to international high-net worth individuals and institutions.
2
| Subsidiary | Financial Conglomerates | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bo Anders Ljungqvist via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree | |
Technical University of Denmark | College/University | Director/Board Member | |
University of Lund | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
University of Copenhagen | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
Survac ApS
![]() Survac ApS Pharmaceuticals: OtherHealth Technology Survac ApS specializes in the development of peptide based therapeutic cancer vaccines. It offers the vaccine candidates for licensing and collaboration agreements. The company's vaccine is being examined in clinical phase I & II trials. Survac was founded in 2003 and is located in Hellerup, Denmark | Pharmaceuticals: Other | Chief Administrative Officer | |
Unimedic AB
![]() Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Takeda Pharmaceuticals International AG
![]() Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Sales & Marketing | |
Coegin Pharma AS
![]() Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chairman | |
XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Lifandis AS
![]() Lifandis AS Internet Software/ServicesTechnology Services Lifandis AS provides access to a wealth of biological samples. It offers data and biological material from the HUNT studies. The company was founded in 2007 and is headquartered in Levanger, Norway. | Internet Software/Services | Chairman Chairman | |
EQL PHARMA AB | Pharmaceuticals: Generic | Chairman | |
Respiratorius AB
![]() Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
CanImGuide Therapeutics AB
![]() CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Chairman | |
Nycomed AB
![]() Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rechon Life Science AB
![]() Rechon Life Science AB Pharmaceuticals: MajorHealth Technology Rechon Life Science AB manufactures medicines. It specializes in aseptic injectables and sprays for nasal and oral administration. The firm's products include Iron Sucrose Injection. The firm's services include formulation and analytical development, clinical trial, stability studies, and storage and distritutions. The company is headquartered in Limhamn, Sweden. | Pharmaceuticals: Major | Sales & Marketing | |
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
LIDDS AB | Pharmaceuticals: Major | Chief Executive Officer | |
APIM Therapeutics AS
![]() APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Medicon Valley Alliance FMBA
![]() Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Medicon Valley Alliance FMBA operates a life science cluster that spans across Denmark and Sweden. The non-profit company is based in the Medicon Valley region. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Regenesance BV
![]() Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | Drugstore Chains | Founder Chairman | |
CASiGEN Pharma Ltd. | Chairman Chairman | ||
Ventac Partners LLC | Founder Founder | ||
Business School Lausanne | College/University | Masters Business Admin | |
CIRCIO HOLDING ASA | Biotechnology | Chief Executive Officer | |
FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Chief Executive Officer | |
IDOGEN AB (PUBL) | Biotechnology | Director/Board Member Director/Board Member | |
ICONOVO AB | Pharmaceuticals: Major | Chairman | |
Neuroscience Technologies Ltd. | Chairman Director/Board Member | ||
COLABITOIL SWEDEN AB (PUBL) | Miscellaneous Commercial Services | Director/Board Member | |
Swedish Growth Fund AB
![]() Swedish Growth Fund AB Investment ManagersFinance Swedish Growth Fund is focusing on biotech, life science and IT companies located in the south of Sweden and in Denmark. The fund makes investments ranging between SEK 5-10 million in companies estimated to be 6-18 months away from an IPO. | Investment Managers | Founder | |
Edvince AB
![]() Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chief Executive Officer Chairman | |
IXALTIS SAS
![]() IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member | |
Swedish Growth Fund Holding AB
![]() Swedish Growth Fund Holding AB Real Estate DevelopmentFinance Swedish Growth Fund Holding AB owns and manages movable property. The company is headquartered in Malmo, Sweden. | Real Estate Development | Chairman | |
CUBE Labs Srl
![]() CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
Bonsig AB
![]() Bonsig AB Real Estate DevelopmentFinance Bonsig AB provides property rental and management services. | Real Estate Development | Director/Board Member | |
AB Glumslövs Tegelbruk | Director/Board Member | ||
Amunix Pharmaceuticals, Inc.
![]() Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
Baltic Gaming AB
![]() Baltic Gaming AB Media ConglomeratesConsumer Services Baltic Gaming AB is a private company that engages in gaming and betting activities. The company is based in Sigtuna, Sweden. The CEO of the Swedish company is Peter Åström. | Media Conglomerates | Director/Board Member | |
Orbit Genomics, Inc.
![]() Orbit Genomics, Inc. Packaged SoftwareTechnology Services Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation. | Packaged Software | Director/Board Member Chairman | |
Asgard Therapeutics AB
![]() Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Asgard Therapeutics AB engages in biotechnological research and development activities. It is in use of cellular reprogramming in cancer immunotherapy, which forces cancer cells to present their own antigens to the immune system, triggering expansion of cancer cell-specific killer T cells and cancer elimination. The company was founded by Filipe Pereira, Cristiana Pires and Fábio Rosa in 2018 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Copenhagen Institute for Futures Studies
![]() Copenhagen Institute for Futures Studies Miscellaneous Commercial ServicesCommercial Services Copenhagen Institute for Futures Studies is an institution that specializes in providing futures studies. The non-profit company is based in Copenhagen, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AMNIOTICS AB | Biotechnology | Chief Executive Officer | |
COEGIN PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Executive Officer | |
Louis Pasteur University | College/University | Doctorate Degree | |
Anders Månsson Business Development AB | Chief Executive Officer | ||
Cenexum Technologies ApS | Chairman |
Statistiques
Internationale
Suède | 26 |
Danemark | 8 |
Norvège | 6 |
Etats-Unis | 4 |
Suisse | 3 |
Sectorielle
Health Technology | 24 |
Consumer Services | 8 |
Finance | 6 |
Commercial Services | 5 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 45 |
Chairman | 29 |
Chief Executive Officer | 18 |
Founder | 18 |
Corporate Officer/Principal | 16 |
Relations les plus connectées
Insiders | |
---|---|
Mikael Ørum | 25 |
Lars Höckenström | 17 |
Mikael Oerum | 17 |
Hans Niclas Göran Lundqvist | 15 |
Anders Månsson | 12 |
Tore Duvold | 11 |
Gunnar Gårdemyr | 11 |
Bo Tandrup | 6 |
Mads Hald Andersen | 5 |
Jette Traulsen | 4 |
Jannie Kogsbøll | 4 |
Per Thor Straten | 2 |
Sachin Mohindra | 1 |
Pierre Rezko | 1 |
Steffen Wad Jørgensen | 1 |
- Bourse
- Insiders
- Bo Anders Ljungqvist
- Connexions Sociétés